-
公开(公告)号:US06319941B1
公开(公告)日:2001-11-20
申请号:US09655897
申请日:2000-09-06
IPC分类号: A61K31415
CPC分类号: C07D231/38 , C07D401/12
摘要: This invention concerns the treatment of smooth muscle spasticity or excess muscle contraction such as urge urinary incontinence with a compound of the formula wherein: R1 and R2 are independently straight chain alkyl of 1 to 6 carbon atoms, branched alkyl of 3 to 6 carbons atoms, or cycloalkyl of 3 to 6 carbons atoms where R1 and R2 may be substituted by F, Cl, Br, I, OH, NH2, cyano, C1-C6 alkoxy, C1-C6alkylthio, COOH or COOC1-C6 alkyl; R3 is an aryl or heteroaryl as defined herein, optionally substituted with 0 to 4 groups selected independently from C1-C6 alkyl, C1-C6 alkoxy, cyano, F, Cl, Br, C1-C6 alkylthio, CO2R1, CONH2, OH, NH2, and NO2; n is 0 or 1; R4 is a straight chain alkyl group of 1 to 10 carbons atoms, a branched alkyl of 3 to 10 carbons, or a cycloalkyl of 3 to 10 carbons; and all crystalline forms and the pharmaceutically acceptable salts thereof.
摘要翻译: 本发明涉及平滑肌痉挛状态或过度肌肉收缩的治疗,例如用糠醛的化合物促进尿失禁:R1和R2分别是1至6个碳原子的直链烷基,3至6个碳原子的支链烷基,或 3至6个碳原子的环烷基,其中R 1和R 2可以被F,Cl,Br,I,OH,NH 2,氰基,C 1 -C 6烷氧基,C 1 -C 6烷硫基,COOH或COOC 1 -C 6烷基取代; R 3是芳基或 任选被0至4个独立地选自C 1 -C 6烷基,C 1 -C 6烷氧基,氰基,F,Cl,Br,C 1 -C 6烷硫基,CO 2 R 1,CONH 2,OH,NH 2和NO 2的基团取代的杂芳基; n 为0或1; R 4为碳原子数为1〜10的直链烷基,碳数为3〜10的支链烷基或碳原子数为3〜10的环烷基;以及所有结晶形式及其药学上可接受的盐。
-
公开(公告)号:US06313149B1
公开(公告)日:2001-11-06
申请号:US09655891
申请日:2000-09-06
IPC分类号: A61K31415
CPC分类号: C07D231/38 , C07D401/12
摘要: This invention concerns the treatment of smooth muscle spasticity or excess muscle contraction such as urge urinary incontinence with a compound of the formula wherein: R1 and R2 are independently straight chain alkyl of 1 to 6 carbon atoms, branched alkyl of 3 to 6 carbons atoms, or cycloalkyl of 3 to 6 carbons atoms where R1 R2 may be substituted by F, Cl, Br, I, OH, NH2, cyano, C1-C6 alkoxy, C1-C6alkylthio, COOH or COOC1-C6 alkyl; R3 is an aryl or heteroaryl as defined herein, optionally substituted with 0 to 4 groups selected independently from C1-C6 alkyl, C1-C6 alkoxy, cyano, F, Cl, Br, C1-C6 alkylthio, CO2R1, CONH2, OH, NH2, and NO2; n is 0 or 1; R4 is a straight chain alkyl group of 1 to 10 carbons atoms, a branched alkyl of 3 to 10 carbons, or a cycloalkyl of 3 to 10 carbons; and all crystalline forms and the pharmaceutically acceptable salts thereof
摘要翻译: 本发明涉及平滑肌痉挛状态或过度肌肉收缩的治疗,例如用糠醛的化合物促进尿失禁:R1和R2分别是1至6个碳原子的直链烷基,3至6个碳原子的支链烷基,或 3至6个碳原子的环烷基,其中R 1可被F,Cl,Br,I,OH,NH 2,氰基,C 1 -C 6烷氧基,C 1 -C 6烷硫基,COOH或COOC 1 -C 6烷基取代; R 3是芳基或杂芳基 任选地被0至4个独立地选自C 1 -C 6烷基,C 1 -C 6烷氧基,氰基,F,Cl,Br,C 1 -C 6烷硫基,CO 2 R 1,CONH 2,OH,NH 2和NO 2基团取代的基团取代; n是 0或1; R 4是碳原子数1〜10的直链烷基,碳原子数3〜10的支链烷基或碳原子数3〜10的环烷基;全部结晶形式及其药学上可接受的盐
-
公开(公告)号:US06172222B2
公开(公告)日:2001-01-09
申请号:US09327065
申请日:1999-06-07
IPC分类号: C07D40112
CPC分类号: C07D231/38 , C07D401/12
摘要: This invention concerns the treatment of smooth muscle spasticity or excess muscle contraction such as urge urinary incontinence with a compound of the formula wherein: R1 and R2 are independently straight chain alkyl of 1 to 6 carbon atoms, branched alkyl of 3 to 6 carbons atoms, or cycloalkyl of 3 to 6 carbons atoms where R1 and R2 may be substituted by F, Cl, Br, I, OH, NH2, cyano, C1-C6 alkoxy, C1-C6alkylthio, COOH or COOC1-C6 alkyl; R3 is an aryl or heteroaryl as defined herein, optionally substituted with 0 to 4 groups selected independently from C1-C6 alkyl, C1-C6 alkoxy, cyano, F, Cl, Br, C1-C6 alkylthio, CO2R1, CONH2, OH, NH2, and NO2; n is 0 or 1; R4 is a straight chain alkyl group of 1 to 10 carbons atoms, a branched alkyl of 3 to 10 carbons, or a cycloalkyl of 3 to 10 carbons; and all crystalline forms and the pharmaceutically acceptable salts thereof.
-
公开(公告)号:US6133273A
公开(公告)日:2000-10-17
申请号:US304180
申请日:1999-05-03
IPC分类号: A61K31/519 , C07D487/04 , A61K31/4162
CPC分类号: C07D487/04 , A61K31/519
摘要: A compound of formula (I) ##STR1## wherein: X=N and Y=CH or X=CH and Y=NR.sub.1 and R.sub.2 are independently, straight chain alkyl of 2 to 12 carbon atoms, branched chain alkyl of 3 to 10 carbon atoms, cycloalkyl of 3 to 10 carbon atoms, aryl of 4 to 10 carbon atoms, 4 to 10 membered heteroaryl or a moiety of the formula (CH.sub.2).sub.m -A wherein m is 1 to 9 and A is cycloalkyl of 3 to 7 carbon atoms; and R.sub.3 is a straight chain alkyl of 1 to 12 carbon atoms, branched chain alkyl of 3 to 10 carbon atoms, aryl of 4 to 10 carbon atoms or 4 to 10 membered heteroaryl for use in the treatment of disorders associated with bone loss by increased transcription and elevation of plasma calcitonin levels.
摘要翻译: 式(I)的化合物,其中:X = N,Y = CH或X = CH,Y = N R 1,R 2独立地为2至12个碳原子的直链烷基,3至10个碳原子的支链烷基, 3至10个碳原子的环烷基,4至10个碳原子的芳基,4至10元杂芳基或式(CH2)mA部分,其中m为1至9,A为3至7个碳原子的环烷基; 并且R 3是1至12个碳原子的直链烷基,3至10个碳原子的支链烷基,4至10个碳原子的芳基或4至10元杂芳基,用于治疗与骨丢失相关的疾病增加 血浆降钙素水平的转录和升高。
-
公开(公告)号:US06458823B1
公开(公告)日:2002-10-01
申请号:US09963254
申请日:2001-09-25
IPC分类号: A61K314155
CPC分类号: C07D231/38 , C07D401/12
摘要: This invention concerns the treatment of smooth muscle spasticity or excess muscle contraction such as urge urinary incontinence with a compound of the formula wherein: R1 and R2 are independently straight chain alkyl of 1 to 6 carbon atoms, branched alkyl of 3 to 6 carbons atoms, or cycloalkyl of 3 to 6 carbons atoms where R2 may be substituted by F, Cl, Br, I, OH, NH2, cyano, C1-C6 alkoxy, C1-C6alkylthio, COOH or COOC1-C6 alkyl; R3 is an aryl or heteroaryl as defined herein, optionally substituted with 0 to 4 groups selected independently from C1-C6 alkyl, C1-C6 alkoxy, cyano, F, Cl, Br, C1-C6 alkylthio, CO2R1, CONH2, OH, NH2, and NO2; n is 0 or 1; R4 is a straight chain alkyl group of 1 to 10 carbons atoms, a branched alkyl of 3 to 10 carbons, or a cycloalkyl of 3 to 10 carbons; and all crystalline forms and the pharmaceutically acceptable salts thereof.
摘要翻译: 本发明涉及平滑肌痉挛状态或过度肌肉收缩的治疗,例如用糠醛的化合物促进尿失禁:R1和R2分别是1至6个碳原子的直链烷基,3至6个碳原子的支链烷基,或 3至6个碳原子的环烷基,其中R 2可以被F,Cl,Br,I,OH,NH 2,氰基,C 1 -C 6烷氧基,C 1 -C 6烷硫基,COOH或COOC 1 -C 6烷基取代; R 3是芳基或杂芳基 任选被0至4个独立地选自C 1 -C 6烷基,C 1 -C 6烷氧基,氰基,F,Cl,Br,C 1 -C 6烷硫基,CO 2 R 1,CONH 2,OH,NH 2和NO 2基团取代的基团取代; n为0 或1; R 4为碳原子数为1〜10的直链烷基,碳原子数为3〜10的支链烷基或碳原子数为3〜10的环烷基;以及所有结晶形式及其药学上可接受的盐。
-
-
-
-